[ad_1] Positive study enables valuable repositioning of new antifibrotic drug candidates by a growing number of pharma companies SAN DIEGO, Oct. 17, 2024 /PRNewswire/ — MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new […]
[ad_1] Positive study enables valuable repositioning of new antifibrotic drug candidates by a growing number of pharma companies SAN DIEGO, Oct. 17, 2024 /PRNewswire/ — MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new […]